Project Number 5P50AG016573-10 Agency/Funding Organization NIA Funding Year 2009 View Full Project Details for EFFECT OF AMYLOID BETA IMMUNOTHERAPY ON TAU AGGREGATES Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) b. Tau Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator LAFERLA, FRANK M Principal Investigator First Name FRANK Principal Investigator Last Name LAFERLA Awardee Organization UNIVERSITY OF CALIFORNIA IRVINE Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-04-011: ALZHEIMER’S DISEASE RESEARCH CENTERS FY Overall Cost $223,873 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PHELPS, CREIGHTON H. Related Resources Repository [NIAGADS] Transethnic GWAS Summary Statistics - Jun et al. (2017) [NIAGADS] ADGC African American Summary Statistics- Reitz et al. (2013) [NIAGADS] ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) [NIAGADS] ADGC Summary Statistics- Naj et al. (2011) [NIAGADS] ADC1- Alzheimer Disease Center Dataset 1 [NIAGADS] ADC2- Alzheimer Disease Center Dataset 2 [NIAGADS] ADC3- Alzheimer Disease Center Dataset 3 University of California Irvine Alzheimer's Disease Center National Alzheimer's Coordinating Center (NACC) [AlzPED] HuCNS-SC Human NSCs Fail to Differentiate, Form Ectopic Clusters, and Provide No Cognitive Benefits in a Transgenic Model of Alzheimer's Disease. Pagination Page 1 Next page ››
